반응식
CC1(C)C(C)(C)OB([C:9]2[CH:17]=[C:16]([C:18]([F:21])([F:20])[F:19])[CH:15]=[C:14]3[C:10]=2[CH:11]=[N:12][NH:13]3)O1.[NH2:23][C:24]1[N:29]=[CH:28][N:27]([CH3:30])[C:26](=[O:31])[C:25]=1Br.[C:33]([O-:36])(O)=[O:34].[Na+]>O1CCOCC1.C1C=CC(P(C2C=CC=CC=2)[C-]2C=CC=C2)=CC=1.C1C=CC(P(C2C=CC=CC=2)[C-]2C=CC=C2)=CC=1.Cl[Pd]Cl.[Fe+2]>[C:33]([OH:36])([C:18]([F:21])([F:20])[F:19])=[O:34].[NH2:23][C:24]1[N:29]=[CH:28][N:27]([CH3:30])[C:26](=[O:31])[C:25]=1[C:9]1[CH:17]=[C:16]([C:18]([F:19])([F:20])[F:21])[CH:15]=[C:14]2[C:10]=1[CH:11]=[N:12][NH:13]2참가 물질
반응물 3
생성물 2
시약·촉매·용매 2
반응 조건
- 온도
- 140 °C
실험 절차
A vial was charged with a mixture of 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-6-(trifluoromethyl)-1H-indazole (0.05 g, 0.160 mmol), 6-amino-5-bromo-3-methylpyrimidin-4(3H)-one (0.042 g, 0.208 mmol) and PdCl2(dppf) (5.86 mg, 8.01 μmol) in dioxane (8 mL) and aqueous saturated NaHCO3 (2 mL). The resulting light brown suspension was heated at 140° C. for 45 minutes in a microwave reactor. The reaction mixture was subsequently concentrated and the crude residue was purified by preparative HPLC, eluting with a gradient of 25-35% ACN (containing 0.035% TFA) in H2O (containing 0.05% TFA) over a period of 4 minutes. The product-containing fractions were combined and the volatiles removed in vacuo to give a TFA salt of the title compound (8 mg, 16%). 1H NMR (400 MHz, CD3OD) δ ppm 3.45 (s, 3H), 7.33 (d, J=1.01 Hz, 1H), 7.83 (s, 1H), 7.89 (d, J=0.76 Hz, 1H), 8.19 (s, 1H); ESI-MS m/z [M+H]+ calc'd for C13H10F3N5O, 310.1. found 310.2.
후처리
- concentrationThe reaction mixture was subsequently concentrated
- customthe crude residue was purified by preparative HPLC
- washeluting with a gradient of 25-35% ACN (containing 0.035% TFA) in H2O (containing 0.05% TFA) over a period of 4 minutes
- customthe volatiles removed in vacuo
출처 및 근거
- ORD 기록
- ord-22a2734188294e14973523a31f111926
- 출처 데이터셋
- uspto-grants-2016_09
- 특허 번호
- US09434743B2
연결된 노트
불러오는 중…